06:32 AM EST, 02/18/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) , a medical cannabis company, was at last look down 1.7% in US premarket trade Tuesday after over the holiday weekend sayin it had in conjunction with MedReleaf Australia recently removed the concession card requirement for patients to access medical cannabis products under the company's IndiMed brand.

By removing this eligibility barrier, the company said any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical cannabis options.

Also, Aurora said it has filed a final short form base shelf prospectus with securities regulators in each of the provinces of Canada, except Quebec, and a corresponding shelf registration statement on Form F-10 with the United States Securities and Exchange Commission.